The International Mesothelioma Program is a center for mesothelioma at the Brigham and Women’s Hospital in Boston, Massachusetts.
International Symposium on Malignant Mesothelioma, hosted by the Mesothelioma Applied Research Foundation, will be held July 22-23 of 2022.
A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appear to be working for patients.
The phase II OT-101 clinical trial will study a promising treatment option for patients with pleural mesothelioma.
Mesothelioma clinical trials work to advance treatment for patients. Learn more about 5 current mesothelioma clinical trials.
Researchers have developed targeted treatment with heat-activated gold spheres (nanotubes) to help with killing mesothelioma tumors.
An anticipated new mesothelioma clinical trial involving a novel drug, RSO-021, will take place at the University of Vermont Cancer Center.
A new cancer treatment (known as monoclonal antibodies) is helping COVID-19 patients with underlying conditions avoid hospitalization.
A promising new artificial intelligence (AI) tool could streamline the process of identifying mesothelioma tumors in patients.
Scientists and researchers are testing new CAR-T cell treatment methods in clinical trials. Learn the timeline and what to expect.